Rapid ICH
RapidAI|
Information source:
Public
Last updated: January 10, 2020 |
General Information
| General | |
|---|---|
| Product name | Rapid ICH |
| Company | RapidAI |
| Subspeciality | Neuro |
| Modality | CT |
| Disease targeted | Intracranial hemorrhage |
| Key-features | |
| Suggested use | |
Technical Specifications
| Data characteristics | |
|---|---|
| Population | |
| Input | |
| Input format | |
| Output | |
| Output format | |
| Technology | |
| Integration | |
| Deployment | |
| Trigger for analysis | |
| Processing time | |
Regulatory
| Certification | |
|---|---|
| CE |
Certified,
Class IIa
, MDD
|
| FDA | 510(k) cleared , Class II |
| Intended Use Statements | |
| Intended use (according to CE) | |
Market
| Market presence | |
|---|---|
| On market since | 02-2020 |
| Distribution channels | |
| Countries present (clinical, non-research use) | |
| Paying clinical customers (institutes) | |
| Research/test users (institutes) | |
| Pricing | |
| Pricing model | |
| Based on | |
Evidence
| Evidence | |
|---|---|
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers | |